The Number 1 Small-Cap Biotech Investors are Missing Out On Post author:Sam Post published:December 26, 2017 Post category:BioPharma A look at a small-cap biotech company that investors should consider. Source: BioSpace You Might Also Like GlaxoSmithKline Gets Expanded FDA Win for Fluarix January 11, 2018 AcelRx Pharma Plans to Resubmit New Drug Application for Dsuvia March 8, 2018 3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year November 20, 2017
